Rheinfelden, Switzerland

Thomas Knöpfel

USPTO Granted Patents = 6 


Average Co-Inventor Count = 10.8

ph-index = 3

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2007-2019

where 'Filed Patents' based on already Granted Patents

6 patents (USPTO):

Title: The Innovative Journey of Thomas Knöpfel: A Pioneer in FGFR4 Inhibitors

Introduction: Thomas Knöpfel, based in Rheinfelden, Switzerland, is a prominent inventor with a remarkable portfolio of six patents. His contributions to the field of medicinal chemistry, particularly in the development of FGFR4 inhibitors, demonstrate his commitment to advancing therapeutic options for various medical conditions.

Latest Patents: Among his notable inventions are two significant patents focusing on ring-fused bicyclic pyridyl derivatives. The first patent describes the use of these compounds as FGFR4 inhibitors, highlighting their therapeutic applications. The second patent elaborates on the compounds' formulations, manufacturing processes, and combinations with pharmacologically active agents to enhance their efficacy. These inventions pave the way for new treatment modalities in oncology and other related fields.

Career Highlights: Throughout his career, Thomas Knöpfel has worked with esteemed companies, including Novartis AG and Novartis Corporation. His innovative work in these organizations has solidified his reputation as a leading figure in drug development and patenting of pharmaceutical compositions.

Collaborations: Thomas Knöpfel has collaborated with talented professionals, including Nicole Buschmann and Robin Alec Fairhurst. These partnerships have facilitated the exchange of ideas and furthered research in the pharmaceutical sector, allowing for groundbreaking developments in drug discovery.

Conclusion: Thomas Knöpfel stands as an influential inventor in the realm of medicinal chemistry, particularly through his work on FGFR4 inhibitors. His six patents reflect not only his innovative spirit but also his dedication to improving healthcare solutions. As research continues to evolve, Knöpfel's contributions will undoubtedly play a crucial role in the future of therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…